Abstract:Ying-Hua Luo, 1, &ast Cheng Wang, 2, &ast Wan-Ting Xu, 3, &ast Yu Zhang, 3 Tong Zhang, 3 Hui Xue, 3 Yan-Nan Li, 3 Zhong-Ren Fu, 3 Ying Wang, 4 Cheng-Hao Jin 3– 5 1 Department of Grass Science, College of Animal Science and Veterinary Medicine, Heilongjiang Bayi Agricultural University, Daqing, 163319, People's Republic of China; 2 Pharmacy Department, Daqing Oilfield General Hospital, Daqing, 163001, People's Republic of China; 3 Department of Biochemistry and Molecular Biology, College of Life Science & Technology, Heilongjiang Bayi Agricultural University, Daqing, 163319, People's Republic of China; 4 College of Food Science and Technology, Heilongjiang Bayi Agricultural University, Daqing, 163319, People's Republic of China; 5 National Coarse Cereals Engineering Research Center, Daqing, 163319, People's Republic of China &astThese authors contributed equally to this work Correspondence: Cheng-Hao Jin; Ying Wang Email ; Background: 18β-glycyrrhetinic acid (18β-Gly), which is extracted from licorice root, has various pharmacological properties; however, its anti-cancer effects on lung cancer cells have not been fully established. Purpose: In this study, we investigated the underlying molecular mechanisms of 18β-Gly. Results: Our results showed that 18β-Gly had significant cytotoxic effects and no apparent side effects. 18β-Gly induced mitochondria-dependent apoptosis of A549 lung cancer cells. In addition, after treatment with 18β-Gly, intracellular reactive oxygen species (ROS) levels were significantly increased, and G2/M cell cycle arrest and inhibition of cell migration were induced via the mitogen-activated protein kinase (MAPK)/signal transducer and activator of transcription 3 (STAT3)/nuclear factor kappa (NF-κB) signaling pathways. After pretreatment with the ROS scavenger N-acetyl-L-cysteine or MAPK inhibitors, the expression levels of phosphorylated p38 (p-p38), phosphorylated c-Jun N-terminal kinase, inhibitor of nuclear factor kappa B, cleaved caspase-3 (cle-cas-3), cleaved poly (ADP ribose) polymerase (cle-PARP), p-p53, p27, p21, and E-cadherin were decreased; and levels of phosphorylated extracellular signal-regulated kinase, p-STAT3, NF-κB, Bcl-2, cyclin B1, cyclase-dependent kinase 1/2 (CDK1/2), N-cadherin, vimentin, and snail homolog 1 (SNAI 1) were increased. In addition, the percentage of cells in the G2/M phase was decreased, and inhibition of migration was reduced. Conclusion: In summary, 18β-Gly induced apoptosis and G2/M cell cycle arrest and inhibited migration via the ROS/MAPK/STAT3/NF-κB signaling pathways in A549 lung cancer cells. Therefore, 18β-Gly is a novel promising candidate for the treatment of lung cancer. Keywords: 18β-glycyrrhetinic acid, lung cancer, apoptosis, cell cycle arrest, ROS, cell migration Lung cancer is one of the most common malignant tumors, with a morbidity and mortality that has rapidly increased globally in recent decades. 1 Despite advances in early detection and treatment strategies for lung cancer, the 5-year survival rate is still below 20%. 2 Treatment options for lung cancer included surgery, chemotherapy, radiation therapy, or a combination. In addition, systemic chemotherapy is commonly used to treat advanced lung cancer by controlling symptoms and prolonging survival. 3 Despite improved chemotherapy, long-term survival in patients with advanced lung cancer remains low. 4 Therefore, it is important to study the pathogenesis and molecular mechanisms of lung cancer, and to identify novel therapeutic drugs with high anti-cancer efficacy and few side effects. In recent years, natural compounds derived from traditional Chinese medicines have become a research hotspot in the development of highly effective anti-cancer drugs with few side effects. 5,6 18β-glycyrrhetinic acid (18β-Gly) is the major bioactive component of Glycyrrhizae Radix, possessing antiulcerative, anti-inflammatory, and antiproliferative properties. 7–9 In addition, 18β-Gly inhibits migration and invasion via the reactive oxygen species (ROS)/protein kinase C-alpha/ERK pathways in human gastric cancer cells. 10 However, to date, the effects of 18β-Gly on lung cancer remain unclear. ROS, mainly produced by mitochondria, play an important role in various signaling pathways. 11 Most research has focused on the regulatory relationship between ROS and downstream signaling pathways. 12,13 Mitogen-activated protein kinase (MAPK) and p53 are two important downstream molecules regulated by ROS, and are involved i -Abstract Truncated-

Identification of Glycogen Phosphorylase L As a Potential Target for Lung Cancer

Integrated Genomic and Proteomic Analyses Identify PYGL As a Novel Experimental Therapeutic Target for Clear Cell Renal Cell Carcinoma

Expression And Significance Of Glucose Transporter-1, P-Glycoprotein, Multidrug Resistance-Associated Protein And Glutathione S-Transferase-Pi In Laryngeal Carcinoma

Protein modifications throughout the lung cancer proteome unravel the cancer-specific regulation of glycolysis

Identifying potential targets for preventing cancer progression through the PLA2G1B recombinant protein using bioinformatics and machine learning methods

Hypoxia Stimulates PYGB Enzymatic Activity to Promote Glycogen Metabolism and Cholangiocarcinoma Progression

Glycogen Phosphorylase B Is Regulated by miR101-3p and Promotes Hepatocellular Carcinoma Tumorigenesis

Transketolase Serves As a Biomarker for Poor Prognosis in Human Lung Adenocarcinoma.

Pyrogallol Suppresses the Tumor Progression via Modulating Aerobic Glycolysis and STAT2 Signaling Pathway in Non-small Cell Lung Carcinoma

Unveiling the role of PYGB in pancreatic cancer: a novel diagnostic biomarker and gene therapy target

Glutathione Peroxidase 8 Expression on Cancer Cells and Cancer-Associated Fibroblasts Facilitates Lung Cancer Metastasis

Glycolysis-related Gene Expression Profiling Serves As a Novel Prognosis Risk Predictor for Human Hepatocellular Carcinoma

Identification of a glycolysis‐related gene signature associated with clinical outcome for patients with lung squamous cell carcinoma

Identification of a novel therapeutic target for lung cancer: Mitochondrial ribosome protein L9

Elevated Nuclear Localization of Glycolytic Enzyme TPI1 Promotes Lung Adenocarcinoma and Enhances Chemoresistance.

6-Phosphogluconate dehydrogenase promotes glycolysis and fatty acid synthesis by inhibiting the AMPK pathway in lung adenocarcinoma cells

Novel Potential Therapeutic Targets of PTPN Families for Lung Cancer

Overexpression of Glycosyltransferase 8 Domain Containing 1 Promotes Gastric Cancer Proliferation and Inhibits Apoptosis via Mediating PTPN6/JAK2/STAT3 Signaling Axis

18β-Glycyrrhetinic Acid Has Anti-Cancer Effects via Inducing Apoptosis and G2/M Cell Cycle Arrest, and Inhibiting Migration of A549 Lung Cancer Cells

Tectoridin and PLK1 inhibitor synergistically promote the apoptosis of lung adenocarcinoma cells: Bioinformatic analysis of TCGA and TCMSP

Gambogic acid exhibits promising anticancer activity by inhibiting the pentose phosphate pathway in lung cancer mouse model